Inventor · disambiguated record
Linda Liang
Also filed as: LIANG LINDA
21 granted patents·10 pending applications·100 citations·filing 2006–2024
93Inventor score
Files withMERCK SHARP & DOHME14MERCK SHARP & DOHME LLC6PIONYR IMMUNOTHERAPEUTICS INC4BRISTOL MYERS SQUIBB CO2FIVE PRIME THERAPEUTICS INC2
Top patents by PatentIndex Score
31 records- 0198US10188730B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2017·Granted Jan 29, 2019·42 cites·41 claims
- 0294US10618958B2Anti-TIGIT antibodiesMERCK SHARP & DOHME·Filed 2017·Granted Apr 14, 2020·10 cites·32 claims
- 0394US10550190B2Phosphate based linkers for intracellular delivery of drug conjugatesMERCK SHARP & DOHME·Filed 2015·Granted Feb 4, 2020·13 cites·4 claims
- 0490US11278620B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2018·Granted Mar 22, 2022·3 cites·8 claims
- 0590US10766957B2Anti-TIGIT antibodiesMERCK SHARP & DOHME·Filed 2016·Granted Sep 8, 2020·7 cites·22 claims
- 0689US9709568B2Antibodies that bind to human programmed death ligand 1 (PD-L1)MERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·14 cites·8 claims
- 0788US10898571B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2018·Granted Jan 26, 2021·2 cites·21 claims
- 0886US2025064924A1Anti-tigit antibodiesMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 0984US12102680B2Anti-TIGIT antibodiesMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 1, 2024·1 cites·30 claims
- 1084US11510993B2Antibody drug conjugate for anti-inflammatory applicationsMERCK SHARP & DOHME·Filed 2016·Granted Nov 29, 2022·3 cites·20 claims
- 1184US10647771B2Antibody that binds to human programmed death ligand 2 (PD-L2) and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted May 12, 2020·4 cites·18 claims
- 1281US12102681B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME LLC·Filed 2022·Granted Oct 1, 2024·0 cites·12 claims
- 1376US12435136B2Antibodies binding to ILT4FIVE PRIME THERAPEUTICS INC·Filed 2022·Granted Oct 7, 2025·0 cites·42 claims
- 1471US11207406B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2018·Granted Dec 28, 2021·0 cites·59 claims
- 1569US2023099074A1Antibody drug conjugate for anti-inflammatory applicationsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1666US12378311B2Anti-MARCO antibodies and uses thereofPORTSMOUTH MERGER SUB II LLC·Filed 2022·Granted Aug 5, 2025·0 cites·31 claims
- 1764US11572407B2Anti-MARCO antibodies and uses thereofPIONYR IMMUNOTHERAPEUTICS INC·Filed 2021·Granted Feb 7, 2023·0 cites·58 claims
- 1864US11401328B2Antibodies binding to ILT4FIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Aug 2, 2022·0 cites·41 claims
- 1964US2025179185A1Anti-trem1 antibodies and related methodsPIONYR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2062US9535074B2Immunoassay for soluble PD-L1MERCK SHARP & DOHME·Filed 2015·Granted Jan 3, 2017·1 cites·17 claims
- 2161US12065491B2Anti-TREM1 antibodies and related methodsPIONYR IMMUNOTHERAPEUTICS INC·Filed 2020·Granted Aug 20, 2024·0 cites·21 claims
- 2260US11958902B2Anti-TIGIT antibodiesMERCK SHARP & DOHME LLC·Filed 2020·Granted Apr 16, 2024·0 cites·1 claims
- 2360US10836828B2Anti-TREM1 antibodies and related methodsPIONYR IMMUNOTHERAPEUTICS INC·Filed 2020·Granted Nov 17, 2020·0 cites·43 claims
- 2457US2017198042A1Anti-tigit antibodiesMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 2557US2017290914A1Anti-lag3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 2655US11045547B2Anti-LAG3 antibodies and antigen-binding fragmentsMERCK SHARP & DOHME·Filed 2016·Granted Jun 29, 2021·0 cites·18 claims
- 2752US2016355589A1Anti-tigit antibodiesWILLIAMS SYBIL M G·Filed 2015·Application pending·0 cites
- 2851US2023333090A1Lag3 antagonist cell based potency assayMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 2949US2023119066A1Anti-ccr8 antibodies for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3046US2021395392A1Anti-mertk antibodies for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 3144US2006286116A1Methods and compositions for treating B cell cancerMORNINGSIDE VENTURE INVEST LTD·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Linda Liang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →